Utipro® Plus AF
Product Description
Noventure
-
Country/Region:Spain
-
Founded:2001
-
On CPHI since:2024
-
Certificates:2
-
Employees:1 - 24
Company types
Primary activities
Categories
Noventure
-
Country/Region:Spain
-
Founded:2001
-
On CPHI since:2024
-
Certificates:2
-
Employees:1 - 24
Company types
Primary activities
More Products from Noventure (2)
-
Product Tasectan® AF
Tasectan® AF is a substance-based medical device composed of xyloglucan (tamarind seed extract) and gelose. This combination acts by forming a film that protects the intestinal mucosa, reducing the frequency and duration of diarrhoeal episodes. The therapeutic effects of the device start from 6 hours after... -
Product Tasectan® AF Kids
Tasectan® AF is a substance-based medical device composed of xyloglucan (tamarind seed extract) and gelose. This combination acts by forming a film that protects the intestinal mucosa, reducing the frequency and duration of diarrhoeal episodes. The therapeutic effects of the device start from 6 hours after...
Noventure resources (2)
-
News New publication for UTIPRO® PLUS / UTIPRO® PLUS AF (The UTISWISS Study)
We are happy to announce the publication of new evidence on the benefit of an antibiotic-free approach (xyloglucan, hibiscus and propolis for oral administration) in the management of uncomplicated urinary tract infections. -
News Tasectan and Xilaplus in the new German GPGN Guidelines
Z Gastroenterol 2024; 62(09): 1574-1643
Getting into treatment guidelines is lengthy, especially for new products that need time to gather sufficient scientific and real-life evidence.

